IDH1 and central nervous system cancer: Mutations in the IDH1 gene have been associated with numerous malignancies including lower-grade gliomas as the mutant IDH1 enzyme catalyzes the conversion of α-KG to D-2-hydroxyglutarate (D-2HG), an oncometabolite [26].